Former Affymetrix Executive Vice President Brings to BioTrove Commercialization
and Operational Experience in the Life Science Business
Woburn, MA, May 30, 2003—BioTrove, Inc. , a privately held biotechnology company focused on leveraging
revolutionary micro- and nano- scale engineering solutions to overcome
current bottlenecks in pharmaceutical drug discovery and biotechnology,
today announced that Robert H. Ellis has joined the company as Chief Operating
Officer. Mr. Ellis brings to BioTrove 29 years of experience in analytical
and biotechnology instrumentation, including 17 years of experience in
the field of genetic and protein analysis. In his role as COO, Mr. Ellis
will oversee the commercialization of the company's Living Chip™
and Lab-on-a-Tape™ nanofluidic drug discovery platforms.
"With his extensive experience at top-tier life science companies,
Bob brings to BioTrove the business expertise and industry knowledge that
will contribute to the continued growth and expansion of the company,"
said Colin J.H. Brenan, Ph.D., President and Chief Executive Officer of
BioTrove. "I am enthusiastic about Bob joining our team and believe
he will be an integral component in the company's efforts to commercialize
our core nanofluidic platforms, the Living Chip and Lab-on-a-Tape."
"Both of BioTrove's platforms, the Living Chip and Lab-on-a-Tape,
are enabling nanofluidic technologies that are uniquely positioned to
address key obstacles in drug development and genomic analysis,"
said Mr. Ellis. "I look forward to working with the team at BioTrove
in addressing the demanding pressure in drug discovery to screen more
targets, find high quality leads and develop more effective assays through
the development of their technologies."
Mr. Ellis joins BioTrove from Affymetrix, where he was Executive Vice
President responsible for R&D efforts for the commercialization of
the company's microarray technology, resulting in the development and
introduction of numerous new products. Previously, Mr. Ellis was President
of Genometrix and held senior executive positions at Applied Biosystems
and Perkin Elmer where he was responsible for strategic marketing and
R&D for Perkin Elmer's Applied Genetics and Nucleic Acid synthesis
units. While at Applied Biosystems, he led the marketing of the world's
first automated DNA sequencer that has generated over $1 billion dollars
in sales since its introduction. Prior to Applied Biosystems, Mr. Ellis
held a number of management positions with the Scientific Instrument Division
of Hewlett Packard. He holds a B.A. from Hartwick College with a Major
in Chemistry and a Minor in Mathematics.
About BioTrove
BioTrove, Inc. is a privately held biotechnology company focused on leveraging
revolutionary micro- and nano-scale engineering solutions to overcome
current bottlenecks in pharmaceutical drug discovery and biotechnology.
BioTrove has two core nanofluidic platforms: the Living Chip™ and
the Lab-on-a-Tape™. BioTrove offers integrated nanoliter storage
and ultra high throughput screening solutions for drug discovery, genetic
engineering, diagnostics and materials science.
For more information contact:
Dr. Colin Brenan
President and Chief Executive Officer
BioTrove, Inc.
cbrenan@biotrove.com
Shannon Altimari
Feinstein Kean Healthcare
saltimari@fkhealth.com
(617) 577-8110
|
